InvestorsHub Logo
Followers 5
Posts 430
Boards Moderated 0
Alias Born 11/05/2013

Re: None

Thursday, 05/07/2015 1:15:46 PM

Thursday, May 07, 2015 1:15:46 PM

Post# of 92948
It's_Unwise To_Do Anything Until RPE Is Done

What if something went wrong? The risk isn't
worth it.

RPE is coming along brilliantly !

When a person can go from only seeing hand movement,
to being able to count fingers on the hand,
IN A FEW DAYS,
that's brilliant!

Why mess with this, with a second program until
this is safely completed? This therapy is new,
many people don't even think it's 'real'.



The talk about platelettes and the bio-reactor chip
is very interesting though. This looks like another
low hanging fruit situation. 5 day span until spoilage,
human donors the only source.

This is a huge unmet need. Or build it and they
will come thing.

Dr. Robert Lanza, UConn Stem Cell, April 27, 2015
(Dr. Lanza talking about COMPLETED RPE Ph1|Ph2A)
(The first SMD patient referred to is Cathy from the Charlie
Rose program below)

(Cathy could only detect hand motion!!!, now she can use her computer, and see details on her carved furniture!)


During that follow up period, we actually found in both the SMD and the AMD patients that they had significant overall visual improvement in the treated eyes. Except for one patient, virtually all of the patients either improved or stabilized during that time period. By contrast, the untreated eyes did not show similar improvement in their visual acuity. And this just shows you an overview of the results, so this is the median visual acuity over baseline. So what you are seeing here with the dotted line is the untreated fellow eye. We treated just one eye, so the untreated eye you can see at 6 months and one year, there was no improvement in vision during that time period. By contrast, the eye that we treated with the RPE cells, here you can see that's the solid blue line. There were 15 letters of improvement in these patients. That represents about three lines of visual improvement in these patients. That's a double in visual angle and is generally considered clinically significant. And many of these patients, for instance, they could only detect hand motion. Within a few days they could actually start to see and count fingers. Eventually they could start reading letters on the visual acuity chart and indeed the first SMD patient that we had that could only detect hand motion, now is out over two years and can read 4 lines, 19 letters on the visual acuity chart, and she can use her computer. People can now go to the mall on their own, so this has made a significant difference in the quality of life for many of these patients.
Dr. Robert Lanza, UConn Stem Cell, April 27, 2015

THIS IS A SLAM-DUNK-A-DUNK OF BURNIN' LOVE !!!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.